Cue Biopharma
CUE
CUE
55 hedge funds and large institutions have $12.8M invested in Cue Biopharma in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 7 closing their positions.
Holders
55
Holders Change
+5
Holders Change %
+10%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
19
Reduced
5
Closed
7
Calls
$47K
Puts
$8K
Net Calls
+$39K
Net Calls Change
+$23K
Top Buyers
1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$688K |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$354K |
3 |
3
Northern Trust
Chicago,
Illinois
|
$227K |
4 |
4
BlackRock
New York
|
$696K |
5 |
HF
5
HRT Financial
New York
|
$53K |